Ballicules.com

Benzonatate

TESSALON

What it isPeripheral antitussive that anesthetizes airway stretch receptors; symptomatic treatment of cough.

Why this oneIt suppresses cough without opioid dependence or routine sedation, but benefit is often modest.

What limits it⚑ Swallow capsules whole: chewing can anesthetize the mouth and compromise the airway. Small pediatric overdoses can be rapidly fatal.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Cough (symptomatic relief)Adults & children >10 yr100-200 mg TID PRN100-200 mg TID PRN600 mg/day in 3 divided doses

Renal Undefined

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy Category C — animal studies not conducted; use only if clearly needed

Lactation Undefined

NO BOXED WARNINGS

Principal riskFatal in overdose in children; never chew the capsule

Cost, est. cash$10–$300/month

Generic entry1993

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Benzonatate ballicule

Benzonatate ballicule: receptor binding, kinetics and half-life diagram

Open Benzonatate in the interactive console ↗